Emerging 2026 Research Is Pointing to a New Root Cause of Blocked Heart Arteries — and What Can Finally Be Done About It
I've spent twenty-five years cutting open heart arteries like the one your cardiologist wants to stent. For most of those twenty-five years, the field didn't have a clear answer for why they kept closing.
That's changed.
Over the last several years, a body of research has been building across heart pathology, cardiology, and hematology journals — and in 2026, what was once a fringe hypothesis is becoming the broadly accepted explanation: the blockage they want to stent is, at its core, a problem of the blood, not the pipe.
You don't need to take my word for it. Open a new tab and type "healed blood clots and artery blockage" into Google. Look at what comes up.
Medical journals. Research universities. Clinical reviews. This isn't fringe. It's where the science has landed.
Here's what that actually means.
What A Healed Clot Is
Right inside your heart artery, every tiny crack gets sealed by your blood with a patch that hardens into a healed clot. Think of it as a ring inside a tree trunk, but alive, and laid down over every crack, every scratch, and every silent tear in your artery, sealing everything in place.
When you're young and your blood is healthy, that patch is laid down and dissolved within days. The crack heals clean underneath it. You don't feel it. It does its job invisibly.
But your blood needs specific enzymes to stay that way — the clot-dissolvers it uses to eat the patch back up, keep the channel wide, and leave nothing behind.
As you age, that clean-up slows down. Your blood makes more fibrinogen every decade, and the brake on dissolving clots climbs with it. Smoking years, stress, cholesterol, and every birthday past 50 speed the process up. The patch stops getting cleared.
So it stacks up.
A clot that never clears loses its soft, temporary quality. It hardens. It stacks. And as it stacks, ring on ring, it begins to physically narrow the artery it was sealing — including the LAD your cardiologist just circled at 70%.
And once you understand that mechanism, every symptom you've been carrying makes sense.
No symptoms, then a 70% blockage
Healed clot builds up inside your heart arteries with no pain on the way in. When ring after ring stacks inside the LAD for ten or twenty years, you feel nothing until a scan says 70% — because the whole thing was built in silence.
The scan that got worse anyway
Your statin is doing its job on the cholesterol in your blood. When fresh clot keeps sealing onto the blockage, the next scan still creeps up.
Every twinge has you wide-eyed
Your blood's brake on dissolving clots peaks around 6:30 every morning, right when heart attacks peak too. A twinge on the stairs feels like the widowmaker because your body already knows the morning is when a clot wins.
Afraid to walk, ride, or travel
When a blockage is on watch, every climb costs more nerve than it should. By the end of the day, you've skipped the walk and put off the cruise — not because your legs gave out, but because you've been bracing for a clot from the inside.
The Research Behind It
This isn't a single study or a fringe theory. It's a converging body of work across multiple labs and journals:
In 142 men who died suddenly, 61% of hearts had healed, layered ruptures — and the more healed sites, the tighter the artery.
In 2,287 patients with stable blockages, adding a stent to full medical therapy didn't lower deaths or heart attacks overall.
One oral dose of nattokinase raised the blood's own clot-breakdown markers within hours compared with placebo, in 12 healthy men.
10,800 FU of nattokinase a day held back carotid artery disease over 12 months — 3,600 FU did not.
These are a few papers out of dozens. All peer-reviewed, all in PubMed, all published in major medical journals.
The 2022 study is the most recent — and it confirms, in 1,062 people, that 10,800 FU of nattokinase a day held artery disease back where 3,600 FU did not.
The findings are public. They've just been slow to reach clinical practice.
Why Nothing You've Tried Has Worked
The stent, the statin, the six-month follow-up — every plan you've been handed for that blockage is designed to do the same thing: fix the pipe and the cholesterol they can see.
None of them touch the reason your blockage keeps growing in the first place. The blood that built it is still there, still sealing fresh clot onto every crack, still laying down the next ring a stent can't reach.
That's why the second stent is so common. Nothing in your medicine cabinet was ever pointed at the blood.
What Fixing The Blood Actually Requires
It's the same mechanism, in reverse.
Your blockage stacked up because your body stopped making enough of what eats fibrin. Give that back, and fresh clot dissolves before it can seal. As it dissolves, the stacking stops. As it stops, the artery holds its line — and the twinges, the 2 a.m. googling, and the countdown dread start to resolve at the source.
There's no shortcut around this. You can't prop the pipe open wide enough, or push the cholesterol low enough, to fix a problem that lives inside the blood. The blood has to be worked on from the inside, with the enzyme it lost.
I spent years recommending the closest things I could find — fish oil, red yeast rice, cheap 2,000 FU nattokinase off the drugstore shelf. I kept coming back to the same conclusion: the ingredients existed, but nothing was putting them together correctly.
So in early 2025, I decided to build the formulation myself.
I teamed up with a small group of heart pathology and blood-clotting researchers, and we spent the better part of a year working through the literature, sourcing the right forms of each ingredient, and testing the formulation. By the end of 2025, we had it.
Noverly Nattokinase
The formulation centers on three core actives — chosen because they're each in the form that actually reaches your blood.
They're supported by bromelain, turmeric, aged garlic, pine bark, grape seed, and dandelion — a matrix that helps the actives absorb and reach the blood.
Every ingredient is research-backed. Every dose is based on what the peer-reviewed literature supports. Nothing is in there for marketing — no proprietary blend, no 2,000 FU token dose, no ingredients that look impressive on a label but don't reach the blood.
What Happened With The First 1,000 Customers
In early 2026 we ran an initial launch and tracked outcomes from our first 1,000 customers across the first 90 days on the protocol. Among those who completed the full 90 days:
These aren't clinical trial numbers. They're self-reported outcomes from real customers — most of whom had a blockage on watch and a stent on the table, and had already tried everything else.
Most reported the shift starting between week three and week six. By day 90, the majority were describing it the same way: not a countdown they were sitting through, but a window they were finally using.
If you've been on watch long enough to know that propping open one spot isn't the same as fixing the blood that built it, Noverly is built for what you've actually been looking for.
Try it for 90 days.
If it doesn't work for you in that window, send it back. Full refund. No questions, no fine print, no return process designed to wear you down. I don't want patients paying for something that isn't helping them.